ST JUDE MEDICAL, LLC
Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|---|---|
| Revenue | $5.54B | $5.62B | $1.36B | $5.50B | $5.50B | $5.16B |
| Operating income | $1.03B | $1.15B | — | $1.05B | $1.10B | $1.28B |
| Net income | $880.0M | $1.00B | $249.0M | $723.0M | $752.0M | $907.4M |
| Total assets | $13.06B | $10.19B | — | $10.25B | $9.27B | $8.57B |
| Total liabilities | $9.02B | $5.95B | — | $5.84B | $5.18B | $4.19B |
| Equity | $4.04B | $4.20B | — | $4.23B | $4.09B | $4.37B |
| EPS (diluted) | $3.07 | $3.46 | $0.86 | $2.49 | $2.39 | $2.75 |
| Shares out. | 283.6M | 281.3M | 283.8M | 282.9M | 320.5M | 325.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- 18.6%
- Net margin
- 15.9%
- Return on equity
- 21.8%
- Return on assets
- 6.7%
- Return on capital (ROCE)
- 9.7%
- Liabilities / assets
- 69.1%
- Debt / equity
- 2.23×
- Book value / share
- $14.25
- Revenue growth (YoY)
- −1.4%
- Net income growth (YoY)
- −12.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Altman Z″ (distress)
- 2.45grey zone
- Accruals / assets
- −1.2%clean
- Beneish M-Score
- -2.43normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 warning● 4 good- Revenue declined year-over-year
- Altman Z″ in the grey zone
- Operating margin is positive
- Strong return on equity (>15%)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Amended charter or bylawsJan 5, 2017
- Director / officer change · Amended charter or bylaws · Shareholder vote · Other material eventOct 27, 2016
- Results of operationsOct 19, 2016
- Other material eventOct 18, 2016
- Results of operationsJul 20, 2016
- Other material eventJul 12, 2016
- Other material eventJun 7, 2016
- Entered a material agreement · Director / officer change · Amended charter or bylaws · Other material eventApr 28, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.